Relapse patterns and management approaches after primary treatment in low-grade non-Hodgkin lymphomas of the spleen

被引：0
|
作者：
Musteata, Vasile
Corcimaru, Ion
Musteata, Larisa
Iacovleva, Iraida
Robu, Maria
Drugus, Ecaterina
机构：
[1] N Testemitanu State Med & Pharmaceut Univ, Inst Oncol, Div Hematol 1, Dept Hematol & Oncol, Kishinev, Moldova
[2] Inst Oncol, Dept Pathol, Kishinev, Moldova
[3] Inst Oncol, Dept Paediat Hematol, Kishinev, Moldova
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：199 / 199
页数：1
相关论文
共 50 条
  • [41] RITUXIMAB AND CHLORAMBUCIL FOR LOW-GRADE NON-HODGKIN'S LYMPHOMA
    Epelbaum, R.
    Kazarin, O.
    Haim, N.
    ANNALS OF ONCOLOGY, 2008, 19 : 231 - 231
  • [42] Immunotherapy for low-grade non-Hodgkin secondary lymphoma of the orbit
    Esmaeli, B
    Murray, JL
    Ahmadi, MA
    Naderi, A
    Singh, S
    Romaguera, J
    White, CA
    McLaughlin, P
    ARCHIVES OF OPHTHALMOLOGY, 2002, 120 (09) : 1225 - 1227
  • [43] Immunotherapy for low-grade non-Hodgkin's lymphoma of the orbit
    Esmaeli, B
    Ahmadi, MA
    Faustina, M
    Murray, JL
    Naderi, A
    Singh, S
    Romaguera, J
    White, CA
    McLaughlin, P
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U381 - U381
  • [44] IGE-PRODUCING LOW-GRADE NON-HODGKIN LYMPHOMA
    SUNDSTROM, C
    NILSSON, K
    BRENNING, G
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1988, 41 (04) : 388 - 395
  • [45] Current therapeutic approaches to patients with newly diagnosed low-grade non-Hodgkin's lymphoma
    Gregory, Stephanie A.
    SEMINARS IN HEMATOLOGY, 2007, 44 (03) : S7 - S11
  • [46] Treatment of low-grade non-Hodgkin lymphomas with fludarabine and mitoxantrone followed by rituximab maintenance: Results of a phase II study.
    Psyrri, Amanda
    Dimopoulos, Meletios A.
    Fountzilas, George
    Tsatalas, Constantinos
    Anagnostopoulos, Athanasios
    Papageorgiou, Sotirios
    Xiros, Nikolaos
    Economopoulos, Theofanis
    BLOOD, 2006, 108 (11) : 261B - 262B
  • [47] Comparison of the DNA content in low and high grade non-Hodgkin lymphomas
    Ruschenburg, L
    Misselwitz, W
    Korabiowska, M
    Droese, M
    ANTICANCER RESEARCH, 1998, 18 (3A) : 1617 - 1620
  • [48] Favorable impact of low-dose fludarabine plus epirubicin and cyclophosphamide regimen (FLEC) as treatment for low-grade non-Hodgkin's lymphomas
    Bocchia, M
    Bigazzi, C
    Marconcini, S
    Forconi, F
    Marotta, G
    Algeri, R
    Lauria, F
    HAEMATOLOGICA, 1999, 84 (08) : 716 - 720
  • [49] PRIMARILY ASYMPTOMATIC LOW-GRADE NON-HODGKIN LYMPHOMAS - PREDICTION OF SYMPTOM-FREE SURVIVAL AND TOTAL SURVIVAL
    MARTINSSON, U
    GLIMELIUS, B
    HAGBERG, H
    SUNDSTROM, C
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1989, 43 (04) : 332 - 338
  • [50] KI-B1 - A MONOCLONAL-ANTIBODY FOR DETECTION AND DIFFERENTIATION OF LOW-GRADE NON-HODGKIN LYMPHOMAS
    PETRASCH, S
    FELLER, AC
    RADZUN, HJ
    WACKER, HH
    BRUHN, HD
    PARWARESCH, MR
    BLUT, 1986, 53 (03): : 218 - 218
12345